Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026)

Savara (SVRA) reported Change in Acquisitions & Divestments of $13.1 million for Q1 2026, down 70.42% year-over-year from $44.4 million in Q1 2025, and down 55.33% on a QoQ basis from $29.4 million in Q4 2025.

Savara (SVRA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $13.1 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 70.42% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.9 million (down 10.11% YoY) and the FY2025 annual result came in at $182.2 million, up 10.42% from the prior year.
  • Change in Acquisitions & Divestments fell to $13.1 million in Q1 2026 per SVRA's latest filing, from $29.4 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $72.3 million in Q2 2022 and bottomed at -$72.3 million in Q3 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $39.3 million (2023), against an average of $31.8 million.
  • Peak annual rise in Change in Acquisitions & Divestments reached 333.04% in 2022, while the deepest fall reached 309.07% in 2022.
  • Tracing SVRA's Change in Acquisitions & Divestments over 5 years: stood at -$72.3 million in 2022, then soared by 162.78% to $45.4 million in 2023, then advanced by 10.02% to $49.9 million in 2024, then slumped by 41.14% to $29.4 million in 2025, then plunged by 55.33% to $13.1 million in 2026.
  • Per Business Quant, the three latest SVRA Change in Acquisitions & Divestments figures stand at $13.1 million (Q1 2026), $29.4 million (Q4 2025), and $44.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.13 Mn
Mar 31, 2026 13.13 Mn
Dec 31, 2025 29.40 Mn
Dec 31, 2025 29.40 Mn
Sep 30, 2025 44.40 Mn
Sep 30, 2025 44.40 Mn
Jun 30, 2025 64.00 Mn
Jun 30, 2025 64.00 Mn
Mar 31, 2025 44.40 Mn
Mar 31, 2025 44.40 Mn
Dec 31, 2024 49.95 Mn
Dec 31, 2024 49.95 Mn
Sep 30, 2024 40.55 Mn
Sep 30, 2024 40.55 Mn
Jun 30, 2024 33.00 Mn
Jun 30, 2024 33.00 Mn
Mar 31, 2024 41.50 Mn
Mar 31, 2024 41.50 Mn
Dec 31, 2023 45.40 Mn
Dec 31, 2023 45.40 Mn
Sep 30, 2023 38.00 Mn
Sep 30, 2023 38.00 Mn
Jun 30, 2023 30.00 Mn
Jun 30, 2023 30.00 Mn
Mar 31, 2023 24.00 Mn
Mar 31, 2023 24.00 Mn
Sep 30, 2022 -72.32 Mn
Sep 30, 2022 -72.32 Mn
Jun 30, 2022 72.32 Mn
Jun 30, 2022 72.32 Mn
Mar 31, 2022 11.28 Mn
Mar 31, 2022 11.28 Mn
Dec 31, 2021 -59.67 Mn
Dec 31, 2021 -59.67 Mn
Sep 30, 2021 34.59 Mn
Sep 30, 2021 34.59 Mn
Jun 30, 2021 16.70 Mn
Jun 30, 2021 16.70 Mn
Mar 31, 2021 16.58 Mn
Mar 31, 2021 16.58 Mn
Dec 31, 2020 15.55 Mn
Dec 31, 2020 15.55 Mn
Sep 30, 2020 65.32 Mn
Sep 30, 2020 65.32 Mn
Jun 30, 2020 -22.52 Mn
Jun 30, 2020 -22.52 Mn
Mar 31, 2020 31.30 Mn
Mar 31, 2020 31.30 Mn
Dec 31, 2019 35.50 Mn
Dec 31, 2019 35.50 Mn
Sep 30, 2019 18.60 Mn
Sep 30, 2019 18.60 Mn
Jun 30, 2019 27.80 Mn
Jun 30, 2019 27.80 Mn
Mar 31, 2019 42.80 Mn
Mar 31, 2019 42.80 Mn
Dec 31, 2018 -54.08 Mn
Dec 31, 2018 -54.08 Mn
Sep 30, 2018 24.85 Mn
Sep 30, 2018 24.85 Mn
Jun 30, 2018 14.20 Mn
Jun 30, 2018 14.20 Mn
Mar 31, 2018 25.30 Mn
Mar 31, 2018 25.30 Mn